Candidate vaccine could provide enhanced breadth of protection against emerging SARS-CoV-2 variants.
Candidate vaccine could provide enhanced breadth of protection against emerging SARS-CoV-2 variants.
People have been a through line in Sarah Morbitzer’s volleyball career. From learning the game by watching her mother coach a local team to her coach and teammates at The Ohio State University, all these people helped Morbitzer on her journey. Graduating this summer, Morbitzer is reflecting on her Buckeye career and what’s next.
NIH-supported study reveals crucial need to increase public awareness that medications for opioid use disorder can be prescribed in primary care settings.
Monoclonal antibody developed from blood of recovering patients.
A generous $20 million gift from Dwight and Dian Diercks will fuel key elements of Mayo Clinic's vision for the future of healthcare, including Mayo Clinic Platform and the application of artificial intelligence (AI) for early detection and intervention in cancer.
The American Society for Virology’s 43rd annual meeting hosted by The Ohio State University this week features some firsts for the organization: It is the largest meeting ever, attracting over 2,000 attendees from 50 countries, and the keynote speaker was a social scientist – rather than a specialist in a biological or medical field.
NOAA and its research partners are forecasting a moderate to above-moderate harmful algal bloom (HAB) in western Lake Erie this summer.
Findings come from an NIH analysis of more than two decades of dietary data from 390,124 U.S. adults.
A barreira hematoencefalica -- uma rede de vasos sanguineos e tecidos que nutre e protege o cerebro de substancias nocivas que circulam no sangue -- e interrompida na doenca de Alzheimer. No momento, pesquisadores e colaboradores da Mayo Clinic descobriram assinaturas moleculares unicas de disfuncao da barreira hematoencefalica que poderiam apontar para novas formas de se diagnosticar e tratar a doenca. Os resultados dessa descoberta estao publicados na Nature Communications.
La barrera hematoencefalica -- una red de vasos sanguineos y tejidos que nutre y protege al cerebro de las sustancias nocivas que circulan en la sangre, se interrumpe en la enfermedad de Alzheimer. En este momento, investigadores y colaboradores de Mayo Clinic han descubierto firmas moleculares unicas de disfuncion de la barrera hematoencefalica que podrian apuntar a nuevas formas de diagnosticar y tratar la enfermedad. Los resultados de este hallazgo estan publicados en Nature Communications.